Laxoberon

Sodium Picosulfate, the active ingredient in Laxoberon, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve occasional constipation in adults and adolescents by promoting bowel movements through increased intestinal motility and fluid secretion.

GNH USA supplies Laxoberon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, ensuring consistent quality and regulatory compliance across markets, with a focus on reliable delivery and technical support.

Sodium Picosulfate is a stimulant laxative used to treat conditions involving reduced bowel motility.

Constipation: promotes regular bowel movements in adults with functional constipation. Occasional constipation: provides short‑term relief of infrequent constipation episodes. Colonoscopy preparation: aids in cleansing the colon prior to diagnostic procedures when used as part of a bowel‑preparation regimen.

Common Side Effects: - Abdominal cramps or discomfort. - Diarrhea or loose stools. - Nausea or mild vomiting. - Flatulence or bloating. - Urgency to defecate. - Headache.

Serious or Rare Side Effects: - Severe dehydration or electrolyte imbalance. - Allergic reactions such as rash, itching, or swelling. - Colonic perforation in cases of underlying obstruction. - Persistent rectal bleeding. - Severe abdominal pain indicating possible colitis.

Before using sodium picosulfate, consider the following precautions: - Assess renal function: adjust use in patients with severe renal impairment. - Monitor electrolyte status: prolonged use may affect potassium and sodium levels. - Avoid in bowel obstruction: risk of perforation. - Use with caution in inflammatory bowel disease: may exacerbate symptoms. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium picosulfate may interact with other medicines as follows:

Major Interactions (Avoid): - Anticholinergic agents: may reduce laxative effect. - Opioid analgesics: may counteract stimulant action. - Lithium: altered absorption may affect lithium levels.

Moderate Interactions (Monitor Closely): - Diuretics: risk of electrolyte disturbances. - Antibiotics altering gut flora: may affect activation of the pro‑drug. - Magnesium‑containing laxatives: additive effect may cause excessive diarrhea.